GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Uchl1 | decreases expression | EXP | | 6480464 | CTD | Valproic Acid results in decreased expression of UCHL1 mRNA; Valproic Acid results in decreased expression of UCHL1 protein | PMID:32526256 | Uchl1 | multiple interactions | EXP | | 6480464 | CTD | [Valproic Acid co-treated with Vitamin A deficiency] affects the expression of UCHL1 protein | PMID:32526256 | Uchl1 | affects expression | ISO | UCHL1 (Homo sapiens) | 6480464 | CTD | Valproic Acid affects the expression of UCHL1 mRNA | PMID:25979313 | Uchl1 | increases expression | ISO | UCHL1 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in increased expression of UCHL1 mRNA | PMID:23179753 PMID:26272509 PMID:27188386 PMID:28001369 PMID:29154799 | Uchl1 | increases expression | ISO | Uchl1 (Mus musculus) | 6480464 | CTD | Valproic Acid results in increased expression of UCHL1 mRNA | PMID:19136453 PMID:21427059 | Uchl1 | multiple interactions | ISO | UCHL1 (Homo sapiens) | 6480464 | CTD | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL1 mRNA | PMID:27188386 | |
Go Back to source page | Continue to Ontology report |